Stem cell treatment for autism spectrum disorder
Part of Mental health clinical trials.
This study tests whether a special type of stem cell (mesenchymal stem cells) can help improve symptoms of autism. It's an early-phase trial, meaning the main goal is to see if the treatment is safe and to gather initial information on how well it might work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 6 years old and weigh at least 17 kg (about 37 pounds).
- Have an autism diagnosis confirmed by standard tests (ADI-R and ADOS-2).
- Either not take psychiatric medications, or be on a steady dose for at least 3 months before joining.
- Be willing to sign a consent form (or have a guardian do it).
- Not have active infections, seizures in the last 6 months, certain genetic conditions, or serious health problems like liver, kidney, or blood diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This study tests whether a combination of stem cell therapy, gut microbiome restoration (using specially prepared stool), and dietary changes can improve autism symptoms, communication, social behavior, and digestive issues. Researchers believe gut health and immune system problems may contribute to autism, and this trial explores whether treating these areas helps.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This trial tests a new therapy that aims to help the brain grow new connections in children with autism. It uses a non-invasive device, so no surgery or drugs are involved, and it may help improve communication and daily skills.
This trial tests a new cell-based treatment (called VGN-Ex05e) for young people with autism who have severe self-injury or aggression that hasn't improved with standard treatments. The treatment is given as a one-time injection into a specific area of the brain (nucleus accumbens) to help calm these behaviors.
This trial tests whether a safe, non-invasive brain stimulation method called repetitive transcranial magnetic stimulation (rTMS) can help children and adolescents with autism spectrum disorder. It aims to see if the treatment is safe and tolerable for this age group.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.